发明名称 HMG1 ANTAGONIST FOR TREATING INFLAMMATORY SYMPTOMS
摘要 PROBLEM TO BE SOLVED: To provide a pharmaceutical composition and method for treating sepsis, including septic shock and ARDS (acute respiratory distress syndrome), comprising administering an effective amount of a HMG1 antagonist.SOLUTION: There is also disclosed a diagnostic method for monitoring the severity or potential lethality of sepsis or septic shock, comprising measuring the serum concentration of HMG1 in a patient exhibiting or at risk for sepsis or septic shock symptoms. There is further disclosed a pharmaceutical composition and method for effecting weight loss or treating obesity, comprising administering an effective amount of HMG1 or a therapeutically active HMG1 fragment.
申请公布号 JP2014031386(A) 申请公布日期 2014.02.20
申请号 JP20130241528 申请日期 2013.11.22
申请人 FEINSTEIN INST FOR MEDICAL RESEARCH 发明人 TRACEY KEVIN J;WANG HAICHAO
分类号 A61K45/00;G01N33/50;A61K31/70;A61K31/7088;A61K38/00;A61K39/395;A61K45/06;A61K48/00;A61P3/04;A61P29/00;A61P31/04;A61P43/00;C07K16/18;G01N33/15;G01N33/68 主分类号 A61K45/00
代理机构 代理人
主权项
地址